MATTHEW P GOETZ, M.D.
Osteopathic Medicine at 1 St, Rochester, MN

License number

Minnesota 41896

Professional information

Associate Professor Of Pharmacology At Mayo Clinic

Position:

Associate Professor of Oncology and Pharmacology at Mayo Clinic

Location:

Rochester, Minnesota

Industry:

Hospital & Health Care

Work:

Mayo Clinic - Rochester, Minnesota Area since Jan 2003 - Associate Professor of Oncology and Pharmacology

Education:

Mayo School of Health Sciences 1999 - 2003
University of Michigan Medical School 1996 - 1999
The University of North Dakota School of Medicine and Health Sciences 1992 - 1996
M.D., Medicine Wheaton College 1988 - 1992
B.A., Music

Matthew P Goetz, Rochester MN

Specialties:

Oncologist

Address:

200 1St St Sw, Rochester, MN 55905

Education:

University of North Dakota, School of Medicine and Health Sciences - Doctor of Medicine

Board certifications:

American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)

Assessing Outcomes For Breast Cancer Patients

US Patent:

2009032, Dec 31, 2009

Filed:

Dec 8, 2006

Appl. No.:

12/096713

Inventors:

Matthew P. Goetz - Rochester MN, US
Fergus J. Couch - Rochester MN, US
James N. Ingle - Rochester MN, US
Vera J. Suman - St. Charles MN, US

International Classification:

A61B 5/00

US Classification:

600300

Abstract:

This document provides methods and materials related to assessing the likely outcome for mammals (e.g., humans) with cancer (e.g., breast cancer). For example, methods and materials for using the ratio of HOXB13 polypeptide expression to IL-17BR polypeptide expression to determine the likelihood of a breast cancer patient to experience breast cancer relapse or death are provided.

Assessing Outcomes For Breast Cancer Patients

US Patent:

2010024, Sep 30, 2010

Filed:

May 18, 2007

Appl. No.:

12/301258

Inventors:

Matthew P. Goetz - Rochester MN, US
James N. Ingle - Rochester MN, US
Fergus J. Couch - Rochester MN, US
Matthew M. Ames - Rochester MN, US

Assignee:

MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH - Rochester MN

International Classification:

C12Q 1/68

US Classification:

435 6

Abstract:

This document provides methods and materials related to assessing the likely outcome for mammals (e.g., humans) with cancer (e.g., breast cancer). For example, methods and materials for using the ratio of HOXB13 polypeptide expression to IL-17BR polypeptide expression, CYP2D6 genotype, medication history, or combinations thereof to determine the likelihood of a breast cancer patient to experience breast cancer relapse or death are provided.

Assessing And Treating Breast Cancer Patients

US Patent:

2011013, Jun 9, 2011

Filed:

Aug 19, 2009

Appl. No.:

13/059590

Inventors:

Matthew P. Goetz - Rochester MN, US
James N. Ingle - Rochester MN, US
Vera J. Suman - Saint Charles MN, US
Matthew M. Ames - Rochester MN, US
Carol Reynolds - Rochester MN, US

International Classification:

A61K 31/138, C12Q 1/02, C12Q 1/68, G01N 33/574, A61P 35/00

US Classification:

514648, 435 29, 435 611, 435 723

Abstract:

This document provides methods and materials related to assessing and treating breast cancer patients. For example, methods and materials that involve assessing a breast cancer patient to determine whether the patient has (1) cancer cells that over express HER-2 polypeptides or comprise a HER-2 amplification and (2) at least an intermediate CYP2D6 metabolizer status are provided.

Assessing Outcomes For Breast Cancer Patients Treated With Tamoxifen

US Patent:

2009020, Aug 20, 2009

Filed:

Dec 8, 2006

Appl. No.:

12/096723

Inventors:

Matthew P. Goetz - Rochester MN, US
James N. Ingle - Rochester MN, US
Richard M. Weinshilboum - Rochester MN, US
Fergus J. Couch - Rochester MN, US
Matthew M. Ames - Rochester MN, US

International Classification:

C12Q 1/68

US Classification:

435 6

Abstract:

This document provides methods and materials related to assessing the likely outcome for mammals (e.g., humans) with cancer (e.g., breast cancer). For example, methods and materials that involve assessing a breast cancer patient's cytochrome P450, family 2, subfamily D, polypeptide 6 (CYP2D6) genotype to determine the likelihood of the beast cancer patient to experience breast cancer relapse or death are provided. Methods and materials that involve assessing the likelihood that a breast cancer patient being treated with tamoxifen will experience side effects such as hot flashes also are provided.

Dr. Matthew P Goetz, Rochester MN - MD (Doctor of Medicine)

Specialties:

Hematology, Medical Oncology, Oncology

Address:

Mayo Clinic
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)

Certifications:

Hematology, 2002, Internal Medicine, 1999, Medical Oncology, 2003

Awards:

Healthgrades Honor Roll

Languages:

English

Education:

Medical School
University Of North Dakota School Of Medicine
Graduated: 1996
University Of Michigan
Graduated: 1997
Graduated: 1999
Mayo Clinic Rochester
Graduated: 2003